企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
AprilBio Co.,Ltd. is a research and development-focused company established in 2013 as a faculty startup, developing antibody therapeutics and long-acting recombinant protein drugs, which belong to protein drugs among biopharmaceuticals, based on human antibody production technology and technology for extending the half-life of protein drugs. The company possesses an antibody library (HuDVFab library) technology that can discover various antibodies and obtain human antibody new drug candidates with the desired target antigen-binding ability, as well as the SAFA (anti-Serum Albumin Fab-Associated technology) platform technology, a long-acting source technology that extends the serum half-life of therapeutic proteins by utilizing a human Fab antibody fragment (named SL335) selected from the company's antibody library that binds specifically and with high affinity to serum albumin.
代表理事
Cha Sanghun
成立日期
2013年1月30日
法人类型
韩国创业板
行业分类
Research and experimental development on medical sciences and pharmacy
法人注册号
14011-0050944
营业执照号
221-81-42488
电话号码
070-4027-7616
传真号码
02-6956-8384
公司地址
1 Kangwondaehak-gil, Chuncheon-si, Gangwon-do
产品与服务
评论